2023 ~ "Carpe Diem"! Seize Today! Don't Miss Out on living for today. Time waits for nobody. The future does show promise, but why wait? BTW: Continue reading for some fresh news about of a clinical trials.
FYI:
today announced that the first subject was dosed in a first-in-human Phase 1 clinical research study with BNT163, a herpes simplex virus (HSV) vaccine candidate for the prevention of genital lesions caused by HSV-2 and potentially HSV-1.
https://investors.biontech.de/news-releases/news-release-details/biontech-starts-phase-1-clinical-trial-prophylactic-herpes/?fbclid=IwAR1KHhJVeYr5wxg6Rq1u6Kst5sZUsK6kfHpNWqe-4QoeWeCziqIHXAh-QQ8